Navigation Links
US Drug Watchdog Now Urges All US Recipients of All Metal Hip Implants to Get a Blood Test For Cobalt-Chromium Levels and They Offer Specific Law Firms For Failure Victims
Date:1/24/2013

(PRWEB) January 24, 2013

The US Drug Watchdog says, “We are convinced the absolute best way for any recipient of a metal on metal hip implant device to see if their all metal hip implant has prematurely failed is to get a simple blood test, that is designed to measure cobalt, and chromium levels in their blood. If the cobalt, or chromium levels are elevated we believe this is a premature failure, and we are urging recipients to get a revision, or replacement surgery, because no one yet knows what elevated levels of cobalt, or chromium will do to a hip implant recipient over time, but we do not think it will be good. We are also urging all metal on metal hip implant failure victims to call us for the names of law firms that have an impressive track record in representing victims that are stuck with a defective medical product." The US Drug Watchdog's new goal is to make certain every US citizen, who is a recipient of a metal on metal hip implant gets a blood test, that is focused on cobalt, and chromium levels, because they do not want to see 100,000's of US citizens crippled, and left holding the bag for a financial, and major health problem that should not be their's. Metal on metal hip implant recipients are encouraged to call the US Drug Watchdog anytime at 866-714-6466 for more information. http://USDrugWatchdog.Com

Metal on Metal Hip Implant Manufacturers that are now subject to national litigation over premature failures include:

  • DePuy Pinnacle Case Number U.S. District Court for the Northern District of Texas MDL#2244
  • DePuy ASR Case Number Ohio Southern Federal District Court Case Number MDL No. 2197AAJ
  • Stryker Rejuvenate Hip Implant Stem Failure Teleseminar: Metallosis with No Metal on Metal Articulation will address the issues surrounding the lates
    '/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. US Drug Watchdog Now Urges Families Of Diabetics Who Used The Diabetes Drug Actos, Developed Bladder Cancer and Died To Call The Johnson Law Group-For A Legal Review
2. US Drug Watchdog Now Urges Transvaginal Mesh Product Failure Victims Who Have Had A Unsuccessful Revision Surgery To Call Them For The Names Of The Best Women Attorneys
3. US Drug Watchdog Now Offers To Help All DePuy Pinnacle Metal on Metal Hip Implant Recipients get to the Best Attorneys Or Law Firms And They Urge Blood Testing For Cobalt
4. US Drug Watchdog Now Urges Yaz Yasmin Birth Control Pill Users Who Suffered a Pulmonary Embolism or Other Serious Medical Issues to Call the Johnson Law Group-ASAP
5. US Drug Watchdog Now Urges Transvaginal Mesh Product Failure Victims Who Have Been Ignored By Their Doctor To Call Them For The Names Of The Best Possible Women Lawyers
6. US Drug Watchdog Now Offers Metal on Metal Hip Implant Recipients Concerned About A Device Failure the Names of the Best Attorneys-If A Blood Test Reveals Elevated Metals
7. US Drug Watchdog Now Urges Families Mourning The Loss Of A Diabetic User Of The Diabetes Drug Called Actos Who Developed Bladder Cancer To Call The Johnson Law Group
8. US Drug Watchdog Now Urges All Victims Of The Transvaginal Mesh Product Failure To Call Them For The Names Of Top Attorneys-Who Are All Women-Don't Get Ignored Any Longer
9. US Drug Watchdog Now Urges All DePuy Pinnacle Hip Implant Recipients to Call Them For the Names of the Best Law Firms if a Blood Test Reveals Elevated Metal Levels
10. US Drug Watchdog Now Urges Women Who Had A Out Of The Blue Heart Attack Or Stroke Who Were Also Using Yaz or Yasmin Birth Control Pills To Call The Johnson Law Group ASAP
11. US Drug Watchdog Now Offers Victims Of A Transvaginal Mesh Product Failure The Names Of The Best Possible Women Lawyers To Help Natiowide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... , , , , ... (Nasdaq: WCRX ) today announced its results for the ... 30, 2009 increased 7.1% to $250.8 million over the prior year ... net sales of DORYX, LOESTRIN 24 FE and ESTRACE Cream which ...
... - Quarter Marked by Launch of RYZOLT(TM) in U.S. -, ... Novel Trazodone, ... , , LAVAL, QC, Aug. 7 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: ... figures are in Canadian dollars unless otherwise stated. , "The second quarter of 2009 was highlighted ...
... ... and technology solutions, today announced the opening of a Chicago field office to better support ... ... Marathon Health, a leading provider of onsite employee health services and technology solutions, ...
... ... vice president for consulting. , ... St. Louis, MO (Vocus) -- Navvis & Company announces the appointment ... the firm and its clients extensive experience and expertise in health system operations, strategic ...
... expensive patients need fewer health care resources and cost insurers ... care team that tracks their health and offers regular support, ... Bloomberg School of Public Health. The research, published in the ... the first eight months of a randomized controlled trial, patients ...
... , WASHINGTON, Aug. 6 Lung Cancer Alliance ... another $11.8 million of the $20 million lung cancer research ... Research Program (CDMRP). , , (Logo: ... The solicitation invited researchers to compete for $10.5 ...
Cached Medicine News:Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 2Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 3Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 4Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 5Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 6Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 7Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 8Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 9Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 10Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 11Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 12Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 13Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 14Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 15Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 16Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 17Health News:Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance 18Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 2Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 3Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 4Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 5Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 6Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 7Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 8Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 9Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 10Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 11Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 12Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 13Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 14Health News:Labopharm Reports Results for Second Quarter Fiscal 2009 15Health News:Marathon Health Expands Midwest Presence 2Health News:Cleveland Joins Navvis & Company 2Health News:Guided care reduces cost of health care for older persons with chronic conditions 2Health News:LCA Announces More Requests for Bids on Lung Cancer Research Programs Funded Through the Department of Defense 2
(Date:1/15/2014)... January 15, 2014 Shire plc (LSE: ... waived the Office of Fair Trading (OFT) approval condition to ... of ViroPharma Incorporated (NASDAQ: VPHM).   As a ... on OFT approval, and Shire expects to complete the tender ... time, subject to the satisfaction of all of the remaining ...
(Date:1/15/2014)... NEW YORK , January 15, 2014 ... subsidiary, BreedIT Ltd., the exclusive worldwide distributor of highly ... announced that on January 7, 2014, the Company,s board ... Ben-Zion Weiner as its new member of ... Weiner held executive positions with Teva Pharmaceutical Industries Ltd ...
(Date:1/15/2014)... Fla. , Jan. 15, 2014  In an unprecedented ... C. difficile and TB in ambulances and other transport vehicles, ... is now being used by rescue personnel for the first ... and transport patients from coming in contact with these deadly ... is the first in the nation to begin sanitizing the ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Superbugs No Longer Ride In Rescue Vehicles 2
... Halozyme Therapeutics, Inc. (Nasdaq: HALO ... Insulin-PH20 (recombinant human insulin with rHuPH20) produced glycemic ... (mealtime) insulin analog. The overall safety and adverse ... and both treatments were well tolerated. Insulin-PH20 achieved ...
... HistoRx, Inc. (privately held), a diagnostics company, announced ... of clinical diagnostic assays based on AQUA® technology. ... specialized laboratory service provider, is launching NexCourse®(1) BCa ... assays based on quantitative immunohistochemistry.  NexCourse BCa by ...
Cached Medicine Technology:Halozyme's rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro 2Halozyme's rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro 3Halozyme's rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro 4Halozyme's rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro 5HistoRx Announces First Clinical Diagnostic Use of AQUA® Technology 2HistoRx Announces First Clinical Diagnostic Use of AQUA® Technology 3
... System supports approaches to Admitting/Discharge/Transfer ... record keeping functions using a ... facilities and cut across institutional ... community clinics, physician, agency, nursing ...
... Dairylands Clinical Information Management ... suite of integrated applications ... departments and automate administrative ... The applications allow organizations ...
... include a Patient Face Sheet, ... many as six custom tabs, ... information is important for you ... Import Manager utility lets you ...
... WEBeDoctor® Physician-office® is an ... physicians, (Solo practice, group ... to complete their normal ... It is a front ...
Medicine Products: